Shunsuke Yanagisawa
Tokyo, 1040045, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Prediction of Overall Survival in Glioblastoma Using Early Postoperative Reduction in FLAIR Lesion Volume After Gross Total Resection.
Journal: Cancers
Published: April 06, 2026
Significance of shunt placement for secondary communicating hydrocephalus in patients with high-grade glioma.
Journal: Journal of neuro-oncology
Published: February 25, 2026
Combination of re-irradiation and bevacizumab for recurrent adult histological pineoblastoma: a case report.
Journal: International cancer conference journal
Published: January 15, 2026
First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
Journal: ESMO open
Published: January 04, 2026
Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database.
Journal: International journal of clinical oncology
Published: December 30, 2025
Durable tumor control with stereotactic radiotherapy and doxorubucin-ifosfamide chemotherapy in primary intracranial sarcoma, DICER1-mutant: a case report.
Journal: International cancer conference journal
Published: December 12, 2025
One-stage Surgery for Malignant Skull and Scalp Tumor: Navigation-guided Tumor Resection and Cranioplasty Using Custom-made Implants: Technical Note.
Journal: Neurologia medico-chirurgica
Published: November 03, 2025
Successful treatment of primary intramedullary spinal cord lymphoma based on the molecular diagnosis of a MYD88 mutation in the cerebrospinal fluid: a case report.
Journal: International cancer conference journal
Published: April 23, 2025
Tirabrutinib rechallenge achieved complete response for recurrent primary central nervous system lymphoma: illustrative case.
Journal: International cancer conference journal
Published: April 13, 2025
Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.
Journal: Japanese journal of clinical oncology
Published: October 10, 2024
Utility of [18F]fluciclovine PET/MRI for identifying the optimal biopsy target region, helping to avoid underdiagnosis in patients with glioblastoma: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: October 07, 2024
Correction to: Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
Journal: Journal of neuro-oncology
Published: September 25, 2024
Last Updated: 09/26/2026